This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Astellas Pharma Gmbh, National Cancer Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 424 
2 out of 263 
Years Active: 2020
Title: Hitoshi Ichikawa: Innovator in Cancer Gene Detection
Introduction
Hitoshi Ichikawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research through his innovative methods for detecting specific genes associated with the disease. With a total of 2 patents, Ichikawa's work is paving the way for advancements in cancer diagnostics.
Latest Patents
Ichikawa's latest patents include a method for detecting the OCLN-ARHGAP26 gene. The objective of this invention is to elucidate a new causative gene of cancer, polynucleotide, and provide a method for detecting the polynucleotide or a polypeptide encoded by it. This detection method identifies a fusion gene of a part of the OCLN gene and a part of the ARHGAP26 gene, or a fusion protein encoded by such a gene. The primer set used in this method includes a sense primer designed from a section encoding OCLN and an antisense primer designed from a section encoding ARHGAP26.
Another significant patent by Ichikawa is the method for detecting the RP2-ARHGAP6 gene. Similar to his previous work, this invention aims to elucidate a new causative gene of cancer, polynucleotide, and provide a method for detecting the polynucleotide or a polypeptide encoded by it. The detection method identifies a fusion gene of a part of the RP2 gene and a part of the ARHGAP6 gene, or a fusion protein encoded by such a gene. The primer set for this method includes a sense primer designed from a section encoding RP2 and an antisense primer designed from a section encoding ARHGAP6.
Career Highlights
Ichikawa has worked with notable organizations such as Astellas Pharma GmbH and the National Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Ichikawa's coworkers include Hiroki Sasaki and Makoto Asaumi. Their collaborative efforts have further enhanced the impact of Ichikawa's inventions in cancer research.
Conclusion
Hitoshi Ichikawa's innovative work in detecting cancer-related genes is a testament to his dedication to advancing medical science. His patents are crucial for developing
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile